TY - JOUR
T1 - Toll-Like Receptor 9 Deficiency Breaks Tolerance to RNA-Associated Antigens and Up-Regulates Toll-Like Receptor 7 Protein in Sle1 Mice
AU - Celhar, Teja
AU - Yasuga, Hiroko
AU - Lee, Hui Yin
AU - Zharkova, Olga
AU - Tripathi, Shubhita
AU - Thornhill, Susannah I.
AU - Lu, Hao K.
AU - Au, Bijin
AU - Lim, Lina H.K.
AU - Thamboo, Thomas P.
AU - Akira, Shizuo
AU - Wakeland, Edward K.
AU - Connolly, John E.
AU - Fairhurst, Anna Marie
N1 - Publisher Copyright:
© 2018 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology
PY - 2018/10
Y1 - 2018/10
N2 - Objective: Toll-like receptors (TLRs) 7 and 9 are important innate signaling molecules with opposing roles in the development and progression of systemic lupus erythematosus (SLE). While multiple studies support the notion of a dependency on TLR-7 for disease development, genetic ablation of TLR-9 results in severe disease with glomerulonephritis (GN) by a largely unknown mechanism. This study was undertaken to examine the suppressive role of TLR-9 in the development of severe lupus in a mouse model. Methods: We crossed Sle1 lupus-prone mice with TLR-9–deficient mice to generate Sle1TLR-9−/− mice. Mice ages 4.5–6.5 months were evaluated for severe autoimmunity by assessing splenomegaly, GN, immune cell populations, autoantibody and total Ig profiles, kidney dendritic cell (DC) function, and TLR-7 protein expression. Mice ages 8–10 weeks were used for functional B cell studies, Ig profiling, and determination of TLR-7 expression. Results: Sle1TLR-9−/− mice developed severe disease similar to TLR-9–deficient MRL and Nba2 models. Sle1TLR-9−/− mouse B cells produced more class-switched antibodies, and the autoantibody repertoire was skewed toward RNA-containing antigens. GN in these mice was associated with DC infiltration, and purified Sle1TLR-9−/− mouse renal DCs were more efficient at TLR-7–dependent antigen presentation and expressed higher levels of TLR-7 protein. Importantly, this increase in TLR-7 expression occurred prior to disease development, indicating a role in the initiation stages of tissue destruction. Conclusion: The increase in TLR-7–reactive immune complexes, and the concomitant enhanced expression of their receptor, promotes inflammation and disease in Sle1TLR9−/− mice.
AB - Objective: Toll-like receptors (TLRs) 7 and 9 are important innate signaling molecules with opposing roles in the development and progression of systemic lupus erythematosus (SLE). While multiple studies support the notion of a dependency on TLR-7 for disease development, genetic ablation of TLR-9 results in severe disease with glomerulonephritis (GN) by a largely unknown mechanism. This study was undertaken to examine the suppressive role of TLR-9 in the development of severe lupus in a mouse model. Methods: We crossed Sle1 lupus-prone mice with TLR-9–deficient mice to generate Sle1TLR-9−/− mice. Mice ages 4.5–6.5 months were evaluated for severe autoimmunity by assessing splenomegaly, GN, immune cell populations, autoantibody and total Ig profiles, kidney dendritic cell (DC) function, and TLR-7 protein expression. Mice ages 8–10 weeks were used for functional B cell studies, Ig profiling, and determination of TLR-7 expression. Results: Sle1TLR-9−/− mice developed severe disease similar to TLR-9–deficient MRL and Nba2 models. Sle1TLR-9−/− mouse B cells produced more class-switched antibodies, and the autoantibody repertoire was skewed toward RNA-containing antigens. GN in these mice was associated with DC infiltration, and purified Sle1TLR-9−/− mouse renal DCs were more efficient at TLR-7–dependent antigen presentation and expressed higher levels of TLR-7 protein. Importantly, this increase in TLR-7 expression occurred prior to disease development, indicating a role in the initiation stages of tissue destruction. Conclusion: The increase in TLR-7–reactive immune complexes, and the concomitant enhanced expression of their receptor, promotes inflammation and disease in Sle1TLR9−/− mice.
UR - http://www.scopus.com/inward/record.url?scp=85054078795&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054078795&partnerID=8YFLogxK
U2 - 10.1002/art.40535
DO - 10.1002/art.40535
M3 - Article
C2 - 29687651
AN - SCOPUS:85054078795
SN - 2326-5191
VL - 70
SP - 1597
EP - 1609
JO - Arthritis and Rheumatology
JF - Arthritis and Rheumatology
IS - 10
ER -